Synapse - Mario Lacouture

Search Within

Mario E Lacouture

Results (457)

The PROTECT Study: A phase II, open-label trial of prophylactic skin toxicity therapy with clindamycin and triamcinolone in patients with glioblastoma treated with tumor-treating fields

Meeting Abstract

Lacouture, M. E.; Ketosugbo, K.; Dusza, S. W.; Goldlust, S. A.; Kumthekar, P.; Iwamoto, F. M.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer

Meeting Abstract

Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Oral minoxidil for the treatment of late alopecia in cancer survivors

Meeting Abstract

Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib

Meeting Abstract

Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

Journal Article

Freites-Martinez, A.; Navitski, A.; Friedman, C. F.; Chan, D.; Goldfarb, S.; Lacouture, M. E.; O'Cearbhaill, R. E.
Gynecologic Oncology Reports (2022)

Fulltext@MSK | Save

Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA -mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP)

Meeting Abstract

Gallagher, E. J.; Moore, H.; Lacouture, M. E.; Dent, S. F.; Farooki, A.; Goncalves, M. D.; Isaacs, C.; Johnston, A.; Juric, D.; Quandt, Z.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Non-invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: A case-series

Journal Article

Bang, A. S.; Monnier, J.; Harris, U.; Garfinkel, J.; Rubinstein, G.; Iftimia, N.; Pulitzer, M.; Murray, M.; Lacouture, M. E.; Jain, M.
Journal of the European Academy of Dermatology and Venereology (2022)

Fulltext@MSK | Save

In reply

Editorial

Lacouture, M. E.; Patel, A. B.; Rosenberg, J. E.; O'Donnell, P. H.
The Oncologist (2022)

Fulltext@MSK | Save

Quality of life before and after treatment of cutaneous metastases with palliative radiotherapy

Research Letter

Reingold, R. E.; Corbett, B. E.; Blank, N. R.; Day, R. A.; McManus, M. J.; Ma, J.; Dusza, S. W.; Lacouture, M. E.; Barker, C. A.; Markova, A.
Journal of the American Academy of Dermatology (2022)

Fulltext@MSK | Save

Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease

Meeting Abstract

Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save